NSF board member resigns, saying Trump’s policies have harmed the agency
By Jeffrey Mervis,
Science
| 05. 13. 2025
“Alondra Nelson” by Sage Ross on Wikimedia Commons
licensed under CC by SA 2.0
In an unprecedented move, a member of the governing body for the National Science Foundation (NSF) resigned today, saying the presidentially appointed advisory board has become a “ceremonial assemblage … without consequence” during the first months of President Donald Trump’s administration.
Sociologist Alondra Nelson was appointed to the National Science Board (NSB) in the final months of former President Joe Biden’s administration, where she had served as acting director of the White House Office of Science and Technology Policy before returning to the Institute for Advanced Study in 2023. Her departure, which she announced this morning in an essay in Time, is believed to be the first time in the agency’s 75-year history that a member of the 24-person board resigned over a policy disagreement with an administration.
“The board should have been far more communicative—with both congressional leaders and the American public—about the changes occurring at NSF,” Nelson tells Science. “Even if these actions were taken without the board’s input or consent, I...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...